hMN14

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hMN14, covering 2021-08-19 to 2021-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer [Phase 1, Phase 2]